HCG vs Testosterone Cypionate
Pregnyl, NovarelvsDepo-Testosterone
HCG and Testosterone Cypionate are both hormone compounds evaluated on Vial: HCG is restricted with clinical-trial evidence, and Testosterone Cypionate is FDA approved with FDA-approval-level clinical evidence, offered by 15 and 27 verified providers respectively.
Vial summary · compiled from public records
At a glance
HCG
Sold as Pregnyl, Novarel
- Category
- Hormone
- FDA / legal status
- Restricted
- Route
- Subcutaneous, intramuscular
Testosterone Cypionate
Sold as Depo-Testosterone
- Category
- Hormone
- FDA / legal status
- FDA Approved
- Route
- Intramuscular, subcutaneous
Side by side
| Field | HCG | Testosterone Cypionate |
|---|---|---|
| Category | Hormone | Hormone |
| Brand names | Pregnyl, Novarel | Depo-Testosterone |
| FDA / legal status | Restricted | FDA Approved |
| Evidence tier | Clinical Trials | FDA Approved |
| Administration route | Subcutaneous, intramuscular | Intramuscular, subcutaneous |
| Compounding access | Restricted | FDA-approved product, dispensed by prescription |
| Providers on Vial | 15 listed | 27 listed |
| Typical price band | $$ to $$$ | $$ to $$$ |
Verified providers offering each
Ranked by Vial Score, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.
About each compound
About HCG
Human chorionic gonadotropin (HCG) is an LH-mimicking hormone used in TRT to maintain testicular function, prevent atrophy, and preserve fertility during exogenous testosterone therapy. It is also used in male hypogonadism as a monotherapy to stimulate endogenous testosterone production. Compounded HCG remains available after FDA discontinued most branded injectable formulations. It is an essential component of fertility-preserving TRT protocols.
About Testosterone Cypionate
A synthetic ester of testosterone, testosterone cypionate is an intramuscularly or subcutaneously administered androgen that provides sustained release of the hormone over approximately one to two weeks. It binds to androgen receptors throughout the body, promoting protein synthesis, muscle development, bone density maintenance, and secondary sex characteristics. The compound is primarily used in the treatment of male hypogonadism and as a component of gender-affirming hormone therapy.
Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.
Related compound comparisons
Other comparisons in the same category.